These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23939596)

  • 21. FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
    Blanc CA; Rosen H; Lane TE
    J Neuroinflammation; 2014 Aug; 11():138. PubMed ID: 25138356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.
    Chun J; Hartung HP
    Clin Neuropharmacol; 2010; 33(2):91-101. PubMed ID: 20061941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
    de Bruin NM; Schmitz K; Schiffmann S; Tafferner N; Schmidt M; Jordan H; Häußler A; Tegeder I; Geisslinger G; Parnham MJ
    Behav Brain Res; 2016 Mar; 300():160-74. PubMed ID: 26692368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring experimental autoimmune optic neuritis using multimodal imaging.
    Manogaran P; Walker-Egger C; Samardzija M; Waschkies C; Grimm C; Rudin M; Schippling S
    Neuroimage; 2018 Jul; 175():327-339. PubMed ID: 29627590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion basis spectrum imaging measures anti-inflammatory and neuroprotective effects of fingolimod on murine optic neuritis.
    Yang R; Lin TH; Zhan J; Lai S; Song C; Sun P; Ye Z; Wallendorf M; George A; Cross AH; Song SK
    Neuroimage Clin; 2021; 31():102732. PubMed ID: 34166868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central nervous system-directed effects of FTY720 (fingolimod).
    Miron VE; Schubart A; Antel JP
    J Neurol Sci; 2008 Nov; 274(1-2):13-7. PubMed ID: 18678377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S1P(1) receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis.
    Gonzalez-Cabrera PJ; Cahalan SM; Nguyen N; Sarkisyan G; Leaf NB; Cameron MD; Kago T; Rosen H
    Mol Pharmacol; 2012 Feb; 81(2):166-74. PubMed ID: 22031473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments.
    Imeri F; Schwalm S; Lyck R; Zivkovic A; Stark H; Engelhardt B; Pfeilschifter J; Huwiler A
    Neuropharmacology; 2016 Jun; 105():341-350. PubMed ID: 26808312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
    Ntranos A; Hall O; Robinson DP; Grishkan IV; Schott JT; Tosi DM; Klein SL; Calabresi PA; Gocke AR
    J Neuroimmunol; 2014 May; 270(1-2):13-21. PubMed ID: 24680062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
    Chiba K; Adachi K
    Future Med Chem; 2012 Apr; 4(6):771-81. PubMed ID: 22530640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.
    Kocovski P; Tabassum-Sheikh N; Marinis S; Dang PT; Hale MW; Orian JM
    Front Immunol; 2021; 12():639650. PubMed ID: 34177891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis.
    Baumruker T; Billich A; Brinkmann V
    Expert Opin Investig Drugs; 2007 Mar; 16(3):283-9. PubMed ID: 17302523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying white matter tract diffusion parameters in the presence of increased extra-fiber cellularity and vasogenic edema.
    Chiang CW; Wang Y; Sun P; Lin TH; Trinkaus K; Cross AH; Song SK
    Neuroimage; 2014 Nov; 101():310-9. PubMed ID: 25017446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis.
    Budde MD; Xie M; Cross AH; Song SK
    J Neurosci; 2009 Mar; 29(9):2805-13. PubMed ID: 19261876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
    Bail K; Notz Q; Rovituso DM; Schampel A; Wunsch M; Koeniger T; Schropp V; Bharti R; Scholz CJ; Foerstner KU; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2017 Jul; 14(1):148. PubMed ID: 28738885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination.
    Slowik A; Schmidt T; Beyer C; Amor S; Clarner T; Kipp M
    Br J Pharmacol; 2015 Jan; 172(1):80-92. PubMed ID: 25220526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.
    Tsai HC; Huang Y; Garris CS; Moreno MA; Griffin CW; Han MH
    JCI Insight; 2016 Jun; 1(9):e86462. PubMed ID: 27699272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment.
    Fujino M; Funeshima N; Kitazawa Y; Kimura H; Amemiya H; Suzuki S; Li XK
    J Pharmacol Exp Ther; 2003 Apr; 305(1):70-7. PubMed ID: 12649354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting synaptic pathology in multiple sclerosis: fingolimod to the rescue?
    Gillingwater TH
    Br J Pharmacol; 2012 Feb; 165(4):858-60. PubMed ID: 21806598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis.
    Budde MD; Kim JH; Liang HF; Russell JH; Cross AH; Song SK
    NMR Biomed; 2008 Jul; 21(6):589-97. PubMed ID: 18041806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.